Specialty Chemicals

Bon Natural Life

Bon Natural Life released FY2025 Q3 earnings on January 23 (EST), actual revenue USD 5.36M, actual EPS USD -0.2077

Bon Natural Life released FY2025 9 Months Earnings on January 23, 2026 (EST), with actual revenue of USD 13.31 M and actual EPS of USD 0.2922

Bon Natural Life released FY2025 Q4 earnings on January 23 (EST), actual revenue USD 5.36 M, actual EPS USD -0.2077

Bon Natural Life released FY2025 Annual Earnings on January 23 (EST), actual revenue USD 18.67 M (forecast USD 58.32 M), actual EPS USD -0.7239

Bon Natural Life released FY2025 Semi-Annual Earnings on September 29, 2025 (EST) with actual revenue of USD 7.95 M and EPS of USD 0.5

Bon Natural Life released FY2025 Q1 earnings on September 29 (EST) with actual revenue of USD 3.975 M and EPS of USD 0.25

Bon Natural Life released FY2025 Q2 earnings on September 29 Post-Market (EST), actual revenue USD 3.975 M, actual EPS USD 0.25

Tianmei Biotech Signs $16 Million Distribution Deal with Huahai Keyuan

Tianmei Bio Enters into a $18 Million Distribution Agreement with Tianjin Meirui Youli

Tianmei Bio Launches Postbiotic Glycemic Ingredients and Signs Exclusive Agreement with Beijing Huahai

Bon Natural Life released FY2024 Annual Earnings on January 28 (EST), actual revenue USD 23.84 M (forecast USD 42.98 M), actual EPS USD 4.14 (forecast USD 145)

Bon Natural Life released FY2024 9 Months Earnings on January 28, 2025 (EST), with actual revenue of USD 10.18 M and actual EPS of USD -0.2045

Bon Natural Life released FY2024 Q4 earnings on January 28, 2025 (EST), with actual revenue of 0 USD and EPS of 0 USD

Bon Natural Life released FY2024 Q3 earnings on January 28 (EST) with actual revenue of 0 USD and EPS of 0 USD

Bon Natural Life released FY2024 Semi-Annual Earnings on September 27 (EST), actual revenue USD 10.18 M (forecast USD 18.25 M), actual EPS USD -0.2045 (forecast USD 62.5)

Bon Natural Life released FY2024 Q1 earnings on September 27, 2024 (EST), with actual revenue of USD 5.092 M and EPS of USD -0.1022

Bon Natural Life released FY2024 Q2 earnings on September 27 (EST), actual revenue USD 5.092 M, actual EPS USD -0.1022

Bon Natural Life released FY2023 Q3 earnings on February 9, 2024 (EST), with actual revenue of 0 USD and EPS of 0 USD

Bon Natural Life released FY2023 Q4 earnings on February 9, 2024 (EST) with actual revenue of 0 USD and EPS of 0 USD

Bon Natural Life released FY2023 earnings on February 9, 2024 (EST), actual revenue USD 29.52 M (forecast USD 34.03 M), actual EPS USD 124.92 (forecast USD 140)

NVIDIA

Alphabet

Alphabet - C

Apple

Microsoft

Amazon

Taiwan Semiconductor

Broadcom

Meta Platforms

Tesla

ORGN

The materials sector presents opportunities to buy undervalued stocks with low RSI values, such as Scully Royalty Ltd (SRL), Bon Natural Life Ltd (BON), and Origin Materials Inc (ORGN). SRL has an RSI of 29.5 and a recent stock price of $6.87, while BON has an RSI of 27.5 and closed at $1.28. ORGN, with an RSI of 14.7, closed at $2.36. These stocks are considered oversold, indicating potential for short-term gains as identified by Benzinga Pro's tools.

benzinga_article

Origin Materials

Scully Royalty

VG Materials

ISHRS S&P Glb Materials

Origin Materials - CW26

Top 3 Materials Stocks That Are Preparing To Pump This Quarter

METCB

LOOP

GURE

ELBM

METC

In Wednesday's after-market session, several materials stocks experienced notable movements. Electra Battery Materials (ELBM) rose 4.6% to $0.61, while Ramaco Resources (METC) increased by 4.13% to $15.44. Other gainers included Bon Natural Life (BON) up 3.57% to $1.33, and Ivanhoe Electric (IE) up 3.11% to $12.59. Conversely, CN Energy Group (CNEY) fell 5.7% to $0.37, Loop Industries (LOOP) declined 4.7% to $1.42, and Gulf Resources (GURE) dropped 3.96% to $7.53. Q4 earnings reports influenced these movements.

Ramaco Resources

Loop Industries

Gulf Resources

Ivanhoe Electric

Electra Battery Materials

Ramaco - CL

First Trust Materials AlphaDEX Fd

11 Materials Stocks Moving In Wednesday's After-Market Session

SBIO

LABU

IBBQ

BON Unveils Strategic Partnership with Tigerbone Group to Launch New Natural Health Initiatives | BON Stock News

StockTitan

Proshares Ultra Nasdaq Biotech

ALPS Medical Breakthrough

iShares Biotechnology ETF

Invesco Biotechnology & Genome ETF

Direxion S&P Biotech Bull 3X

VanEck Biotech ETF

Invesco Nasdaq Biotechnology ETF

SPDR S&P Biotech

First Trust NYSE Arca Biotech Index Fd

BON Unveils Strategic Partnership with Tigerbone Group to Launch New Natural Health Initiatives | BON Stock News

Bon Natural Life Limited (Nasdaq: BON) has launched a kombucha-inspired product and signed a $12 million strategic sales agreement with Shaanxi Qingshengyuan Health Industry Co., Ltd. The agreement, lasting 24 months, involves the distribution of BON's tea-pigment products in Greater China. This collaboration aims to expand BON's presence in the functional product industry and enhance market awareness of its ingredient technologies.

BON Unveils Kombucha-Inspired Product, Inks $12 Million Strategic Sales Agreement with Qingshengyuan | BON Stock News

Bon Natural Life(BON.US)

Top 3 Materials Stocks That Are Preparing To Pump This Quarter

11 Materials Stocks Moving In Wednesday's After-Market Session

BON Unveils Strategic Partnership with Tigerbone Group to Launch New Natural Health Initiatives | BON Stock News

BON Unveils Kombucha-Inspired Product, Inks $12 Million Strategic Sales Agreement with Qingshengyuan | BON Stock News